Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Galectin Therapeutics Q2 EPS $(0.15) Down From $(0.11) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.15) per share. This is a 36.36 percent decrease over losses of $(0.11) per share from the same period last year.

byBenzinga Newsdesk

August 16, 2021

1 minute read

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.15) per share. This is a 36.36 percent decrease over losses of $(0.11) per share from the same period last year.